{"issuance_frequency":"","notes_translated":{"fr":"Ce document fournit des lignes directrices sur l'élaboration des éléments de preuve et des documents nécessaires pour obtenir une autorisation et une licence en vue de l'importation ou de la vente d'un vaccin contre la COVID-19 au Canada.","en":"This document provides guidance on developing the evidence and documentation needed to obtain an authorization and licensing for importing or selling a COVID-19 vaccine in Canada."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"2a3e20e4-ae17-4e98-8069-eab1edb64481","metadata_created":"2021-07-27T14:01:51.483274","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-27T14:01:51.483281","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-27","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["coronavirus","COVID-19","pandémie","médicaments","médicaments","vaccins","autorisation de mise sur le marché","licence","importation ou vente","vaccin COVID-19"],"en":["coronavirus","COVID-19","pandemic","drugs","medications","vaccines","market authorization","licensing","importing or selling","COVID-19 vaccine"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Aperçu","en":"Guidance for market authorization requirements for COVID-19 vaccines: Overview"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"2a3e20e4-ae17-4e98-8069-eab1edb64481","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"38f9f541-8a23-413a-b754-fc5e581a44ec","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Aperçu","en":"Guidance for market authorization requirements for COVID-19 vaccines: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Overview","language":["en"],"created":"2021-07-27T14:01:51.576111","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines.html","last_modified":null,"position":0,"revision_id":"61c5e683-6f8f-4042-b65a-6d7d8abd8a6c","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2a3e20e4-ae17-4e98-8069-eab1edb64481","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f825fb26-1845-4a9d-8dd5-a8831cfdb9ac","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Aperçu","en":"Guidance for market authorization requirements for COVID-19 vaccines: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Overview","language":["fr"],"created":"2021-07-27T14:01:51.576116","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins.html","last_modified":null,"position":1,"revision_id":"61c5e683-6f8f-4042-b65a-6d7d8abd8a6c","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-04-06 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"2a3e20e4-ae17-4e98-8069-eab1edb64481","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This document provides guidance on developing the evidence and documentation needed to obtain an authorization and licensing for importing or selling a COVID-19 vaccine in Canada.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance for market authorization requirements for COVID-19 vaccines: Overview","revision_id":"61c5e683-6f8f-4042-b65a-6d7d8abd8a6c"}